Learn More
Medchemexpress LLC 2-((5-bromo-2-((1-(methylsulfonyl)piperidin-4-yl)amino)pyrimidin-4-yl)amino)-6-fluorobenzamide | 2488892-01-7 | 99.4% | 487.35 g/mol | C17H20BrFN6O3S | 10 MG

Supplier: Medchemexpress LLC HY15106910MG
TMX-2039 is a research-grade pan-cyclin-dependent kinase (pan-CDK) inhibitor intended for biochemical and cellular studies of cell cycle and transcriptional CDKs. Supplied as an off-white to light yellow solid with high reported purity, it is suitable for assay development, mechanism-of-action experiments, and probe validation in research settings.
- Pan-CDK activity covering cell cycle and transcriptional CDKs.
- High purity (≈99.4%) suitable for research applications.
- Supplied as a solid powder for flexible formulation and dosing.
- Available in small research-friendly pack sizes, e.g. 10 mg.
- Stable under recommended storage: 4°C under nitrogen; in solvent, -80°C for 6 months or -20°C for 1 month.
- Provides consistent material for biochemical and cellular assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.